Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arformoterol vs Tiotropium in COPD Re-hospitalization
NCT02275481Phase 4Terminated
- Sponsor
- Sumitomo Pharma America
- Start
- Nov 2014
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of arformoterol in chronic obstructive pulmonary disease (COPD), sponsored by Sumitomo Pharma America. Started Nov 2014; status: terminated.
02
Drugs
arformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02275481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02275481.